Abstract
Abstract
Background
The diagnosis, management and prognosis of microinvasive breast carcinoma remain controversial.
Methods
We analysed the outcomes of patients with DCIS with and without microinvasion diagnosed between 2003 and 2012 within the Sloane project.
Results
Microinvasion was recorded in 521 of 11,285 patients (4.6%), with considerable variation in reported incidence among screening units (0–25%). Microinvasion was associated with high-grade DCIS, larger DCIS size, comedo necrosis and solid, cribriform architecture (all P < 0.001). Microinvasion was more frequent in patients who underwent mastectomy compared with breast-conserving surgery (BCS) (6.9% vs 3.6%, P < 0.001), and in those undergoing axillary nodal surgery (60.4% vs 30.3%, P < 0.001) including the subset undergoing BCS (43.4% vs 8.5%, P < 0.001). Nodal metastasis rate was low and not statistically significant difference from the DCIS only group (P = 0.68). Following median follow-up of 110 months, 3% of patients had recurrent ipsilateral high-grade DCIS, and 4.2% developed invasive carcinoma. The subsequent ipsilateral invasion was of Grade 3 in 71.4% of patients with microinvasion vs 30.4% in DCIS without microinvasion (P = 0.02). Distant metastasis and breast cancer mortality were higher with microinvasion compared with DCIS only (1.2% vs 0.3%, P = 0.01 and 2.1% vs 0.8%; P = 0.005).
Conclusions
The higher breast cancer mortality with microinvasion indicates a more aggressive disease.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. The WHO Classification of Tumours Editorial Board. WHO Classification of tumours—breast tumours, 5th Edition. Lyon: International Agency for Research On Cancer (IARC); 2019.
2. Guidelines Working Group of the UK National Coordinating Committee for Breast Pathology. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html. Accessed 1 September 2022. The Royal College of Pathologists; 2016.
3. Adamovich TL, Simmons RM. Ductal carcinoma in situ with microinvasion. Am J Surg. 2003;186:112–6. https://doi.org/10.1016/s0002-9610(03)00166-1.
4. Champion CD, Ren Y, Thomas SM, Fayanju OM, Rosenberger LH, Greenup RA, et al. DCIS with microinvasion: is it in situ or invasive disease? Ann surgical Oncol. 2019;26:3124–32. https://doi.org/10.1245/s10434-019-07556-9.
5. van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surgical Oncol: J Eur Soc Surgical Oncol Br Assoc Surgical Oncol. 2008;34:631–5. https://doi.org/10.1016/j.ejso.2007.08.003.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献